Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cells.

Front Pharmacol

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.

Published: August 2024

[This corrects the article DOI: 10.3389/fphar.2017.00476.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331309	PMC
http://dx.doi.org/10.3389/fphar.2024.1418274	DOI Listing

Publication Analysis

corrigendum proteasome

proteasome inhibitor

inhibitor ysy01a

ysy01a abrogates

abrogates constitutive

constitutive stat3

stat3 signaling

signaling down-regulation

down-regulation gp130

gp130 jak2

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!